Haimovitz Jules has filed 10 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 25640 shares of Armata Pharmaceuticals, Inc. ($ARMP) on March 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Armata Pharmaceuticals, Inc. | $ARMP | Haimovitz Jules | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| May 19, 2025 | Innoviva, Inc. | $INVA | Haimovitz Jules | Director | A | Non-statutory Stock Option | 10000 | $0.00 | 10,000.0000 | 74,187,000 | 9999.99% | 0.01% |
| May 19, 2025 | Innoviva, Inc. | $INVA | Haimovitz Jules | Director | A | Common Stock | 12077 | $0.00 | 142,906.0000 | 74,187,000 | 9.23% | 0.02% |
| Feb. 5, 2025 | Armata Pharmaceuticals, Inc. | $ARMP | Haimovitz Jules | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| June 17, 2024 | Innoviva, Inc. | $INVA | Haimovitz Jules | Director | A | Non-statutory Stock Option | 10000 | $0.00 | 30,000.0000 | 86,876,000 | 50.00% | 0.01% |
| June 17, 2024 | Innoviva, Inc. | $INVA | Haimovitz Jules | Director | A | Common Stock | 13923 | $0.00 | 130,829.0000 | 86,876,000 | 11.91% | 0.02% |
| March 14, 2024 | Armata Pharmaceuticals, Inc. | $ARMP | Haimovitz Jules | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| March 14, 2024 | Armata Pharmaceuticals, Inc. | $ARMP | Haimovitz Jules | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |
| May 22, 2023 | Innoviva, Inc. | $INVA | Haimovitz Jules | Director | A | Non-statutory Stock Option | 10000 | $0.00 | 20,000.0000 | 95,248,000 | 100.00% | 0.01% |
| May 22, 2023 | Innoviva, Inc. | $INVA | Haimovitz Jules | Director | A | Common Stock | 16495 | $0.00 | 116,906.0000 | 95,248,000 | 16.43% | 0.02% |